Australian Clinical Labs Ltd
ASX:ACL

Watchlist Manager
Australian Clinical Labs Ltd Logo
Australian Clinical Labs Ltd
ASX:ACL
Watchlist
Price: 3.5 AUD 0.86% Market Closed
Market Cap: 700.8m AUD
Have any thoughts about
Australian Clinical Labs Ltd?
Write Note

Intrinsic Value

The intrinsic value of one ACL stock under the Base Case scenario is 4.89 AUD. Compared to the current market price of 3.5 AUD, Australian Clinical Labs Ltd is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ACL Intrinsic Value
4.89 AUD
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Australian Clinical Labs Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ACL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ACL?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Australian Clinical Labs Ltd

Provide an overview of the primary business activities
of Australian Clinical Labs Ltd.

What unique competitive advantages
does Australian Clinical Labs Ltd hold over its rivals?

What risks and challenges
does Australian Clinical Labs Ltd face in the near future?

Has there been any significant insider trading activity
in Australian Clinical Labs Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Australian Clinical Labs Ltd.

Provide P/S
for Australian Clinical Labs Ltd.

Provide P/E
for Australian Clinical Labs Ltd.

Provide P/OCF
for Australian Clinical Labs Ltd.

Provide P/FCFE
for Australian Clinical Labs Ltd.

Provide P/B
for Australian Clinical Labs Ltd.

Provide EV/S
for Australian Clinical Labs Ltd.

Provide EV/GP
for Australian Clinical Labs Ltd.

Provide EV/EBITDA
for Australian Clinical Labs Ltd.

Provide EV/EBIT
for Australian Clinical Labs Ltd.

Provide EV/OCF
for Australian Clinical Labs Ltd.

Provide EV/FCFF
for Australian Clinical Labs Ltd.

Provide EV/IC
for Australian Clinical Labs Ltd.

Show me price targets
for Australian Clinical Labs Ltd made by professional analysts.

What are the Revenue projections
for Australian Clinical Labs Ltd?

How accurate were the past Revenue estimates
for Australian Clinical Labs Ltd?

What are the Net Income projections
for Australian Clinical Labs Ltd?

How accurate were the past Net Income estimates
for Australian Clinical Labs Ltd?

What are the EPS projections
for Australian Clinical Labs Ltd?

How accurate were the past EPS estimates
for Australian Clinical Labs Ltd?

What are the EBIT projections
for Australian Clinical Labs Ltd?

How accurate were the past EBIT estimates
for Australian Clinical Labs Ltd?

Compare the revenue forecasts
for Australian Clinical Labs Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Australian Clinical Labs Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Australian Clinical Labs Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Australian Clinical Labs Ltd compared to its peers.

Compare the P/E ratios
of Australian Clinical Labs Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Australian Clinical Labs Ltd with its peers.

Analyze the financial leverage
of Australian Clinical Labs Ltd compared to its main competitors.

Show all profitability ratios
for Australian Clinical Labs Ltd.

Provide ROE
for Australian Clinical Labs Ltd.

Provide ROA
for Australian Clinical Labs Ltd.

Provide ROIC
for Australian Clinical Labs Ltd.

Provide ROCE
for Australian Clinical Labs Ltd.

Provide Gross Margin
for Australian Clinical Labs Ltd.

Provide Operating Margin
for Australian Clinical Labs Ltd.

Provide Net Margin
for Australian Clinical Labs Ltd.

Provide FCF Margin
for Australian Clinical Labs Ltd.

Show all solvency ratios
for Australian Clinical Labs Ltd.

Provide D/E Ratio
for Australian Clinical Labs Ltd.

Provide D/A Ratio
for Australian Clinical Labs Ltd.

Provide Interest Coverage Ratio
for Australian Clinical Labs Ltd.

Provide Altman Z-Score Ratio
for Australian Clinical Labs Ltd.

Provide Quick Ratio
for Australian Clinical Labs Ltd.

Provide Current Ratio
for Australian Clinical Labs Ltd.

Provide Cash Ratio
for Australian Clinical Labs Ltd.

What is the historical Revenue growth
over the last 5 years for Australian Clinical Labs Ltd?

What is the historical Net Income growth
over the last 5 years for Australian Clinical Labs Ltd?

What is the current Free Cash Flow
of Australian Clinical Labs Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Australian Clinical Labs Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Australian Clinical Labs Ltd

Balance Sheet Decomposition
Australian Clinical Labs Ltd

Current Assets 133.6m
Cash & Short-Term Investments 26.8m
Receivables 81.4m
Other Current Assets 25.3m
Non-Current Assets 459.5m
Long-Term Investments 2.1m
PP&E 281.7m
Intangibles 164.9m
Other Non-Current Assets 10.7m
Current Liabilities 207.7m
Accounts Payable 53m
Other Current Liabilities 154.7m
Non-Current Liabilities 207.8m
Long-Term Debt 204.2m
Other Non-Current Liabilities 3.6m
Efficiency

Earnings Waterfall
Australian Clinical Labs Ltd

Revenue
696.4m AUD
Cost of Revenue
-119.3m AUD
Gross Profit
577m AUD
Operating Expenses
-519.1m AUD
Operating Income
57.9m AUD
Other Expenses
-34m AUD
Net Income
23.9m AUD

Free Cash Flow Analysis
Australian Clinical Labs Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ACL Profitability Score
Profitability Due Diligence

Australian Clinical Labs Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROIC
64/100
Profitability
Score

Australian Clinical Labs Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

ACL Solvency Score
Solvency Due Diligence

Australian Clinical Labs Ltd's solvency score is 23/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Short-Term Solvency
Positive Net Debt
23/100
Solvency
Score

Australian Clinical Labs Ltd's solvency score is 23/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACL Price Targets Summary
Australian Clinical Labs Ltd

Wall Street analysts forecast ACL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACL is 3.59 AUD with a low forecast of 2.98 AUD and a high forecast of 4.2 AUD.

Lowest
Price Target
2.98 AUD
15% Downside
Average
Price Target
3.59 AUD
2% Upside
Highest
Price Target
4.2 AUD
20% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ACL?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ACL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ACL Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Australian Clinical Labs Ltd Logo
Australian Clinical Labs Ltd

Country

Australia

Industry

Health Care

Market Cap

700.8m AUD

Dividend Yield

3.43%

Description

Australian Clinical Labs Ltd. provides pathology services. The company is headquartered in Melbourne, Victoria and currently employs 2,794 full-time employees. The company went IPO on 2021-05-14. The firm is engaged in private hospital pathology businesses in regions of Western Australia, Victoria, South Australia and the Northern Territory. Its brands include Australian Clinical Labs, SunDoctors, Helix Pathology, Southern Sun, BeFunctional Labs and Gribbles Veterinary Pathology. The Australian Clinical Labs provides pathology in Australia, servicing clinicians, patients, hospitals, commercial clients and public organizations. The SunDoctors offers diagnosis and treatment of skin cancer. The Helix Pathology delivers specialized histopathology and cytology testing services. The Southern Sun is the skin cancer lab and the commercial lab in Australia. The BeFunctional Labs assists practitioners in the diagnosis, treatment and management of patients by providing functional pathology tests. The Gribbles Veterinary Pathology provides animal health professionals with pathology service.

Contact

VICTORIA
Melbourne
1868-1892 Dandenong Road, Clayton
+61300453688.0
www.clinicallabs.com.au

IPO

2021-05-14

Employees

2 794

Officers

CEO & Executive Director
Ms. Melinda McGrath
Chief Executive Officer of Victoria
Mr. Darren McKee
Chief Financial Officer
Mr. Matthew Cordingley
Chief Operating Officer
Mr. Anthony Friedli
Chief Information Officer
Mr. Sean Jackson
National Marketing Director
Mr. Joe Geran
Show More
National Medical Director & Chief Pathologist
Associate Prof. Tony Landgren
Chief Executive Officer of New South Wales & Australian Capital Territory
Mr. Chris Brownlow
Chief Executive Officer of WA/SA/NT
Ms. Shae Seymour
Company Secretary
Ms. Eleanor Padman B.A., FCIS
Show Less

See Also

Discover More
What is the Intrinsic Value of one ACL stock?

The intrinsic value of one ACL stock under the Base Case scenario is 4.89 AUD.

Is ACL stock undervalued or overvalued?

Compared to the current market price of 3.5 AUD, Australian Clinical Labs Ltd is Undervalued by 28%.

Back to Top